Inventor

SRIVASTAVA SURESH C

US55 patents

⚠️ This page may combine multiple inventors who share the name “SRIVASTAVA SURESH C”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SRIVASTAVA SURESH C

CHEMGENES CORP

Oligonucleotide phosphate esters

N-protected-2&#39;-O-methyl-ribonucleosides and N-protected 2&#39;-O-methyl-3&#39;-cyanoethyl-N-,N-diisopropyl phosphoramidite ribonucleosides

Propargyl modified nucleosides and nucleotides

Synthesis of novel azo-dyes and their use in oligonucleotide synthesis

RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end

Oligonucleotides and related compounds

RT-qPCR molecular detection and diagnosis

Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA and as diagnostics tools

RNA synthesis—phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end

Therapeutic compositions and uses

Dithiolane functionalized nucleoside amidites and supports for stronger immobilization of bio-molecules on solid surfaces

Highly efficient synthesis of long RNA using reverse direction approach

SRIVASTAVA SURESH C

Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3&#39;-end ligands, chromophores and modifications of synthetic RNA

RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3′-end

Palladium-109 labeled anti-melanoma monoclonal antibodies

Method of electroplating a conversion electron emitting source on implant

Synthesis of labile base protected-modified deoxy and modified ribo nucleosides, corresponding phosphoramidites and supports and their use in high purity oligonucleotide synthesis

Synthesis of deuterated ribo nucleosides N-protected phosphoramidites, and oligonucleotides

Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides

Method of treating a human being for a class of neurological defects and seizure disorders

Method of synthesis and purification of N-6-trimethyl-L-lysine and derivative compounds

Method of treating a human being for a class of metabolic defects and energy production disorders

Synthesis of N-FMOC protected deoxy nucleosides, ribo nucleosides, modified deoxy and ribo nucleosides, and phosphoramidites, and their use in oligonucleotide synthesis

ASS UNIVERSITIES INC

Macrocyclic polyaminocarboxylates for stable radiometal antibody conjugates for therapy, spect and pet imaging

Cyclohexyl EDTA monoanhydride

Synthesis of macrocyclic polyaminocarboxylates and their use for preparing stable radiometal antibody immunoconjugates for therapy, spect and pet imaging

Synthesis of 4-substituted-trans-1, 2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging

Stable radiometal antibody immunoconjugates

Cyclohexyl-triethylenetetraamine hexacetic acid

Method and kit for the selective labeling of red blood cells in whole blood with TC-99M

Kit for the selective labeling of red blood cells in whole blood with 9 TC

BROOKHAVEN SCIENCE ASS LLC

Radiopharmaceutical stannic Sn-117m chelate compositions and methods of use

Method for palliation of pain in human bone cancer using therapeutic tin-117m compositions

Rigid bifunctional chelating agents

Radiopharmaceutical compositions

Rigid bifunctional chelating agents

Formulation for Tin-117m /diethylenetriaminepentaacetic acids

Therapeutic tin-117m compositions

Process for the manufacture of 117Sn diethylenetriaminepentaacetic acids

US ENERGY

Tin-117m-labeled stannic (Sn4+) chelates

Complex of transferrin with ruthenium for medical applications

Radionuclide labeled lymphocytes for therapeutic use

Preparation of high specific activity technetium-96

ASED LLC

Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites and oligonucleotides

Synthesis of deuterated ribo nucleosides, N-protected phosphoramidites, and oligonucleotides

UNIV NEW YORK STATE RES FOUND

Radiolabeled antiplatelet monoclonal antibody for imaging in-vivo thrombi

(unassigned)

Synthesis of 4-substituted-trans-1,2-diaminocyclohexyl polyaminocarboxylate metal chelating agents for the preparation of stable radiometal antibody immunoconjugates for therapy and spect and pet imaging

LAIKHTER ANDREI

Method of oligonucleotide labeling using cycloaddition reaction

SRIVASTAV SANT K

Nucleosides and oligonucleotides for studies on reversal of cytotoxic and mutagenic damage of DNA potential diagnostics tools

ZHUIKOV BORIS L

Targets and methods for target preparation for radionuclide production

N-protected-2'-O-methyl-ribonucleosides and N-protected 2'-O-methyl-3'-cyanoethyl-N-,N-diisopropyl phosphoramidite ribonucleosides

Phosphoramidites for synthetic RNA in the reverse direction, efficient RNA synthesis and convenient introduction of 3'-end ligands, chromophores and modifications of synthetic RNA